Literature DB >> 24967468

[Low-dose chemotherapy is highly effective in adults with sporadic or HIV-associated Burkitt's lymphoma].

Gabriele Reinartz, Hans Theodor Eich.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24967468     DOI： 10.1007/s00066-014-0666-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

Authors:  Wyndham H Wilson; Sin-Ho Jung; Pierluigi Porcu; David Hurd; Jeffrey Johnson; S Eric Martin; Myron Czuczman; Raymond Lai; Jonathan Said; Amy Chadburn; Dan Jones; Kieron Dunleavy; George Canellos; Andrew D Zelenetz; Bruce D Cheson; Eric D Hsi
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

2.  Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.

Authors:  M Diviné; P Casassus; S Koscielny; J Bosq; C Sebban; C Le Maignan; A Stamattoulas; B Dupriez; M Raphaël; J-L Pico; V Ribrag
Journal:  Ann Oncol       Date:  2005-11-10       Impact factor: 32.976

3.  Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.

Authors:  T Wästerlid; P N Brown; O Hagberg; H Hagberg; L M Pedersen; F D'Amore; M Jerkeman
Journal:  Ann Oncol       Date:  2013-02-27       Impact factor: 32.976

Review 4.  Adult Burkitt leukemia and lymphoma.

Authors:  Kristie A Blum; Gerard Lozanski; John C Byrd
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

5.  Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Authors:  Satish Gopal; Monita R Patel; Elizabeth L Yanik; Stephen R Cole; Chad J Achenbach; Sonia Napravnik; Greer A Burkholder; Erin G Reid; Benigno Rodriguez; Steven G Deeks; Kenneth H Mayer; Richard D Moore; Mari M Kitahata; Joseph J Eron; Kristy L Richards
Journal:  J Natl Cancer Inst       Date:  2013-07-26       Impact factor: 13.506
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.